Urgency lacking as TB passes Covid as biggest killer: ExpertTuberculosis, once called consumption, was the world's biggest infectious killer before the arrival of Covid-19, with 1.5 million people dy...
23 Oct, 2022, 08.13 AM IST
TB Alliance in talks with government over use of new shorter BPaL RegimenIndia has the world's highest TB burden-- 2.6 million active cases and close to 450,000 deaths each year from the infectious bacterial dise...
06 Sep, 2022, 01.04 AM IST
Lupin, TB Alliance join hands for new therapy for drug-resistant tuberculosisTB Alliance President and CEO Mel Spigelman said that partnering with Lupin -- a well-established manufacturer with experience delivering h...
06 Sep, 2021, 12.53 PM IST
BPaL regimen can cut time for treatment of drug-resistant TBBPaL is a six-month, alloral, three-drug regimen that is used to treat people with highly drug-resistant forms of TB. It consists of the TB...
22 Jul, 2021, 10.28 AM IST
Mylan, TB Alliance seeks clinical trial waiver for Pretomanid drugPretomanid, a new oral treatment is a shorter more convenient option for people with extensively drug resistant (XDR) TB. The dossier for g...
01 Nov, 2019, 10.27 PM IST
Mumbai pharma company gets licence for breakthrough TB drugA global non-profit drug developer TB Alliance has tied up with domestic company Macleods Pharmaceuticals to develop and commercialise its ...
28 Oct, 2019, 10.14 AM IST
States must invest in R&D to fund new drug discoveries: TB AllianceGeneric manufacturers are essential players in the fight to end TB so we do speak with generic manufacturers as part of our access strategy.
26 Sep, 2018, 06.08 PM IST